# Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas

> **NCT00148109** · PHASE2 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 36 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** Cetuximab
- **DRUG:** Cetuximab

## Key facts

- **NCT ID:** NCT00148109
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-07
- **Final completion:** 2009-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2013-01-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00148109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00148109, "Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00148109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*